Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortFirst new kind of schizophrenia drug in decades.Effective antipsychotic with notable weight gain.
Body systemMental HealthMental Health
Drug classMuscarinic antipsychoticsSecond-generation antipsychotics
SupplyPrescription onlyPrescription only
Main usesSchizophrenia in adultsSchizophrenia, Bipolar mania, Agitation (injection), Chemotherapy nausea (low dose)
How it worksSwitches on brain receptors that indirectly calm dopamine, while a second ingredient blocks gut side effects.Calms psychosis and mania.
Starts working——
Half-life—21–54 hours
Typical adult doseStart 50/20 mg twice a day, increasing to 100/20 then up to 125/30 mg twice a day, at least 1 hour before or 2 hours after food.5–20 mg once a day.
FormsCapsuleTablet, Orodispersible tablet, Injection, Long-acting injection
Common side effectsNausea, Indigestion, Constipation, Vomiting, Raised heart rate, DizzinessWeight gain, Sleepiness, Increased appetite, Dizziness
Serious side effectsUrinary retention, Angioedema, Raised liver enzymesDiabetes and high lipids, Neuroleptic malignant syndrome (rare)
Don't take if—Narrow-angle glaucoma (caution); Dementia-related psychosis (increased mortality); Known risk of diabetes (caution)
Alcohol—Best avoided. Alcohol adds to sedation.
PregnancyUse with cautionLimited data.Use with cautionUsed when needed; monitor for gestational diabetes.
Breastfeeding—Use with cautionSmall amounts in milk; watch for sedation and weight.
In use since20241996
Brand namesUnited States: CobenfyUnited States: Zyprexa, Lybalvi (with samidorphan)United Kingdom: ZyprexaIndia: Oleanz, Olace
Legal status—United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC code—N05AH03

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker